Elevated Baseline CA19-9 Levels Correlate With Adverse Prognosis in Patients With Early- Or Advanced-Stage Pancreas Cancer
Medical Oncology - United States
doi 10.1007/s12032-012-0278-9
Full Text
Open PDFAbstract
Available in full text
Date
June 24, 2012
Authors
Publisher
Springer Science and Business Media LLC